March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Quantitative Autofluorescence (qAF) in Best Vitelliform Macular Dystrophy
Author Affiliations & Notes
  • Tobias Duncker
    Ophthalmology, Columbia University, New York, New York
  • Jonathan P. Greenberg
    Ophthalmology, Columbia University, New York, New York
  • Theodore Smith
    Ophthalmology, Columbia University, New York, New York
  • Stephen H. Tsang
    Ophthalmology, Columbia University, New York, New York
  • François C. Delori
    Schepens Eye Research Institute, Harvard Medical School, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Tobias Duncker, None; Jonathan P. Greenberg, None; Theodore Smith, None; Stephen H. Tsang, None; François C. Delori, None
  • Footnotes
    Support  NEI R01 EY015520, New York Community Trust (RTS), Foundation Fighting Blindness
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 2683. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Tobias Duncker, Jonathan P. Greenberg, Theodore Smith, Stephen H. Tsang, François C. Delori; Quantitative Autofluorescence (qAF) in Best Vitelliform Macular Dystrophy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):2683.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose:
 

To compare quantitative measurements obtained from fundus autofluorescence images in Best disease to normal controls.

 
Methods:
 

10 patients with electrooculography confirmed Best disease (5-57 years, mean 31±21 years) were studied, including 4 subclinical cases. Autofluorescence (AF) images were acquired with the Spectralis SLO-OCT (Heidelberg Eng.) modified by insertion of an internal AF reference to account for variable laser power and detector sensitivity [Delori et al, IOVS, 2011]. Maximum qAF within the central 30° field was measured in 1 eye per patient, both for normal appearing background retina and, if present, within the macular lesion (Figure 1). The results were compared to a fixed temporal region in normal controls (1 eye per subject), which generally represented the highest qAF levels in this group.

 
Results:
 

The background retina from 8 out of 10 patients, including 2 out of 4 subclinical cases, showed qAF values significantly above the 95%CI of age similar controls (Figure 2). Macular lesions always exhibited the highest qAF readings within the 30° field, with up to 7 times higher qAF levels than maximum background retina.

 
Conclusions:
 

The background retina in Best patients shows high maximum qAF levels compared to age similar controls. This suggests increased lipofuscin accumulation outside the visible macular lesions. qAF may enhance our understanding of Best disease, and aid in the identification of subclinical cases.  

 

 
Keywords: imaging/image analysis: clinical • ipofuscin • retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×